重组干扰素α - 2a (roferon-A)治疗卡波西肉瘤合并艾滋病5例

Q4 Medicine

Medicina cutanea ibero-latino-americana Pub Date : 1989-01-01

E Lopez Bran, R Aguilar, J A Marron, M A Figueredo, J M Garcia Ruiz

{"title":"重组干扰素α - 2a (roferon-A)治疗卡波西肉瘤合并艾滋病5例","authors":"E Lopez Bran, R Aguilar, J A Marron, M A Figueredo, J M Garcia Ruiz","doi":"","DOIUrl":null,"url":null,"abstract":"alpha-2A-interferon is a useful and safe drug in Kaposi's sarcoma treatment although not free of serious side-effects when used at therapeutic dosages by which strict controls must be undertaken. When treatment has been interrupted, worsening and dissemination of the disease happened. No correlation has been found between immunologic parameters and the treatment used.","PeriodicalId":18373,"journal":{"name":"Medicina cutanea ibero-latino-americana","volume":"17 4","pages":"269-73"},"PeriodicalIF":0.0000,"publicationDate":"1989-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].\",\"authors\":\"E Lopez Bran, R Aguilar, J A Marron, M A Figueredo, J M Garcia Ruiz\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"alpha-2A-interferon is a useful and safe drug in Kaposi's sarcoma treatment although not free of serious side-effects when used at therapeutic dosages by which strict controls must be undertaken. When treatment has been interrupted, worsening and dissemination of the disease happened. No correlation has been found between immunologic parameters and the treatment used.\",\"PeriodicalId\":18373,\"journal\":{\"name\":\"Medicina cutanea ibero-latino-americana\",\"volume\":\"17 4\",\"pages\":\"269-73\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina cutanea ibero-latino-americana\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina cutanea ibero-latino-americana","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

α - 2a -干扰素是治疗卡波西肉瘤的一种有效且安全的药物，尽管在必须严格控制的治疗剂量下使用时并非没有严重的副作用。当治疗中断时，疾病就会恶化和传播。未发现免疫参数与所使用的治疗方法之间存在相关性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].

alpha-2A-interferon is a useful and safe drug in Kaposi's sarcoma treatment although not free of serious side-effects when used at therapeutic dosages by which strict controls must be undertaken. When treatment has been interrupted, worsening and dissemination of the disease happened. No correlation has been found between immunologic parameters and the treatment used.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Medicina cutanea ibero-latino-americana Medicine-Dermatology

自引率

0.00%

发文量

期刊介绍： La Revista Medicina Cutánea Ibero-Latino-Americana se adhiere a los “Requisitos de uniformidad para manuscritos presentados para publicación en revista biomédicas” elaborados por el Comité Internacional de Editores de Revista Médicas